Sheela Foam Ltd

- The acquisition of Kurlon was funded through a mix of cash, debt, and QIP equity: - Approximately INR 2,350 crores total funding required. - Around INR 800 crores from available cash. - About INR 600 crores raised via debt. - Approximately INR 1,000 crores planned through QIP equity issuance. - No incremental capex-driven fundraising planned for the foreseeable future, except maintenance capex (INR 10-20 crores for Sheela Foam, INR 10 crores for Kurlon). - Net debt to EBITDA target is around 2 to 2.5 times at end of FY '24, expected to reduce to less than 1 times in subsequent years. - Conservative on debt profile to avoid rating deterioration. - No further cash infusions expected for Furlenco beyond current investment as it is targeted to become EBITDA positive by October 2023 and PBT positive by December 2023.

- Post Kurlon acquisition, Sheela Foam does not plan significant capacity expansion since existing plants have surplus capacity. - Future capex will primarily focus on maintenance, estimated around INR 10-20 crores for Sheela Foam and ~INR 10 crores for Kurlon. - New plant setups are driven more by geographical market proximity to reduce transportation costs than capacity constraints. - Exceptional or incremental capex will be considered only if new business opportunities arise. - The Jabalpur expansion is underway, with commissioning in progress and market piloting started; full operation expected by September-October. - Focus remains on leveraging cost synergies and strengthening market presence without heavy capital outlay.

- SleepX rationalization is largely done; future impact from it on sales will be positive or neutral. - Topline drop partly due to SleepX reduction and raw material price-linked price adjustments, especially in India, Australia, and Spain. - Raw material prices stabilizing at lower levels expected to improve bottom-line going forward. - Post-acquisition, Kurlon’s regional strength is expected to complement Sleepwell’s, driving growth beyond simple sum of parts. - Expansion via leveraging Kurlon's presence in South and East India and Sleepwell's presence in North and West India should increase overall volumes and revenue. - No explicit sales growth guidance provided yet; cautious approach to forecasts due to ongoing market conditions. - Cost synergies expected to fund enhanced marketing for brand and category development to boost sales. - Jabalpur plant commissioning progressing; sales ramp-up expected by Q3 or Q4 FY24. - Full capacity utilization potential suggests ability to quadruple current production volumes if market demand grows.

- The company is cautious about giving specific futuristic guidance currently (Page 14). - Positive impact expected from SleepX rationalization and raw material price normalization, suggesting improving margins and profitability ahead (Page 14-15). - The raw material price decline benefit on gross margins is expected to continue as inventory resets (Page 15). - Acquisitions of Kurlon and Furlenco are expected to create significant value and synergies, likely contributing to revenue and margin growth over time (Pages 8-15). - Consolidated EBITDA expected to be around INR250-300 crores for FY24, with net debt-to-EBITDA ratio aimed at 2-2.5x in FY24 and reducing below 1x in subsequent years (Page 7). - Capacity utilization indicates potential for volume growth without immediate heavy capex (Pages 10-11). - The integration of Kurlon and leveraging regional brand strengths are expected to increase revenue beyond the sum of parts (Page 11). - Full appreciation of goodwill and acquisition-related returns will be clearer post detailed assessment (Page 15). Overall, moderate near-term growth with stronger profitability and cash flow expected post acquisitions and cost normalization.

The transcript provided does not explicitly mention details about the current or expected order book or pending orders for Sheela Foam Limited. However, some related insights can be noted: - The company continues to supply to Indian Railways and remains a flagship supplier despite increasing competition. - The Jabalpur expansion is progressing with commissioning ongoing; piloting in the market has begun. - Export orders, especially to the US, are currently small due to anti-dumping duties and market conditions. - The Sleepwell brand is growing in e-commerce, replacing the loss-making SleepX segment, indicating a strategic shift in order fulfillment channels. - The acquisition of Kurlon (pending transfer of some shares to the operating company) will add about INR 1,000 crores to topline, indicating a significant addition to order inflows and capacity. No specific numerical data on actual order backlog or pending orders is disclosed in this transcript.